General MedicationsORALStandard
PROCHLORPERAZINE MALEATE
PROCHLORPERAZINE MALEATE
Standard Dose
EQ 5MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview PROCHLORPERAZINE MALEATE is listed in Drugs@FDA under application 218912 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient PROCHLORPERAZINE MALEATE Form and strength TABLET;ORAL - EQ 5MG BASE Sponsor LEADING Submission history Latest submission status date: 2024-09-30 00:00:00.
Structured Monograph
Clinical summary
Approval overview PROCHLORPERAZINE MALEATE is listed in Drugs@FDA under application 218912 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient PROCHLORPERAZINE MALEATE Form and strength TABLET;ORAL - EQ 5MG BASE Sponsor LEADING Submission history Latest submission status date: 2024-09-30 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.